Search results
Whistleblower
- Dinesh Thakur, an American-educated chemical engineer, was hired by Ranbaxy, back in 2003. He would later become a whistleblower, exposing massive fraud by the generic pharmaceutical giant, a company that sold Americans drugs like the generic version of Lipitor.
www.cbsnews.com/news/ranbaxy-whistleblower-reveals-how-he-exposed-massive-pharmaceutical-fraud/
People also ask
What did Thakur do at Ranbaxy?
What happened to Ranbaxy?
Who is Dinesh Thakur?
How did Ranbaxy determine drug content?
May 15, 2013 · NEW DELHI: Dinesh Thakur, the former Ranbaxy executive who pocketed Rs 244 crore ($48 million) for blowing the whistle on the dubious manufacturing practices of the country's largest drug maker, has made some of his peers and ex-colleagues turn green with envy.
Jun 17, 2019 · While at Ranbaxy, Mr. Thakur discovered that the company was falsifying drug data and violating current good manufacturing practices and good laboratory practices. He resigned in 2005 after reporting the fraud to company management, and worked with authorities for eight years to unravel the complicated trail of falsified records and dangerous ...
Jun 4, 2013 · Dinesh S. Thakur, who between 2003 and 2005 was the director and global head, research information and portfolio management at Ranbaxy, was the whistleblower.
Dinesh Thakur is a former Ranbaxy executive who blew the whistle on massive fraud at the pharma giant. An investigation sparked by Thakur’s exposé led to the company paying around $500...
- 75 min
- 134.9K
- newslaundry
Aug 12, 2019 · In short, Ranbaxy had almost no method for confirming the content of drugs in those markets. For example, the data collected by Thakur’s team showed that of the 163 drug products approved in Brazil since 2000, almost all had been filed with phony batch records and stability data that did not exist. ADVERTISEMENT.
Nov 6, 2013 · Dinesh Thakur, an American-educated chemical engineer, was hired by Ranbaxy, back in 2003. He would later become a whistleblower, exposing massive fraud by the generic pharmaceutical giant, a...
Mar 7, 2016 · Thakur, who worked for Ranbaxy for two years from 2003 before turning whistleblower, is now chief executive of Florida-based MedAssure Global Compliance, which advises drug companies on quality...
